Komori
Dividends2395SHIN NIPPON BIOMEDICAL LABORATORIES,LTD.Information and Communications, Services and Others

Notice Regarding the Distribution of Surplus

The Company has decided to pay an interim dividend of ¥20.00 per share for the fiscal year ending March 2027. This is unchanged from the latest dividend forecast and the actual dividend for the same period of the previous fiscal year.

Worth reading
66In focus
Scored from 4 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
20
¥ per share
Wording
Definitive
How definitive the wording is.

Dividend per share

Fiscal year ending March 2027
50YenRevised annual dividend per sharePrevious forecast ¥50, change ¥0(0.0%)
Previous-period resultsPrevious forecastAfter revision

Each vertical step represents one dividend payment, and the total height of the accumulated steps represents the annual dividend for the period. For periods showing only the annual amount, the payment breakdown is not provided, so only the end point is plotted.

Dividend per shareyen/sen¥20→¥200.0%
Total dividendsTotal amount payable to all shareholders¥832 million→¥832 million
Whether Submission to the General Meeting of Shareholders Is RequiredBoard of directors resolution only
Record date30 September 2026
Effective date30 November 2026

The record date is the cutoff date for determining which persons listed in the shareholder register on that date are entitled to receive dividends.Payments begin on the effective date.

Payout ratioTargeting a consolidated dividend payout ratio of 30–40%The percentage of earnings paid out as dividends.
Source of dividendsRetained earningsThe source of dividend payments. Depending on the type of surplus, the dividend may be paid from earned profits or may be closer to a return of capital.
Dividend policy

The Company regards stable profit distributions to shareholders as one of its important management policies and has adopted as its basic policy the determination of dividends with a consolidated dividend payout ratio of 30–40% as a guideline, taking into account underlying earnings power, cash flow conditions and other factors.

Dividend per share
ItemDetails
Dividend per share¥20.00 → ¥20.00(0%)
Total Annual Dividends¥50.00 → ¥50.00(0%)
Previous-period results (per share)Interim ¥20.00 / End of period ¥30.00 / Annual ¥50.00
Total dividends¥832 million → ¥832 million
Record date30 September 2026
Effective date30 November 2026
Source of dividendsRetained earnings
Payout ratioTargeting a consolidated dividend payout ratio of 30–40%
Dividend policyThe Company regards stable profit distributions to shareholders as one of its important management policies and has adopted as its basic policy the determination of dividends with a consolidated dividend payout ratio of 30–40% as a guideline, taking into account underlying earnings power, cash flow conditions and other factors.
Whether Submission to the General Meeting of Shareholders Is RequiredBoard of directors resolution only
Fiscal Period CoveredFiscal year ending March 2027
Items this document does not state (1)
Breakdown of Regular, Commemorative and Special Dividends

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

This is based on the policy of prioritising stable profit distributions and making decisions with a consolidated dividend payout ratio of 30–40% as a guideline, taking into account underlying earnings power and cash flow conditions. The Company believes that performance for the interim consolidated accounting period of the fiscal year ending March 2027 progressed steadily.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Distribution of Surplus | SHIN NIPPON BIOMEDICAL LABORATORIES,LTD. (2395) timely disclosure | Komori